Dr. Gerald P. Parzmair currently serves as Chief Development Officer at Memo Therapeutics AG since December 2022. Prior to this role, Dr. Parzmair held various leadership positions at Serum Life Science Europe, including Chief Operating Officer and Chief Scientific Officer, since July 2016. Experience also includes a research position at Helmholtz Centre for Infection Research from October 2012 to June 2016, and a lab management role at Medical University of Graz from December 2008 to October 2012. Dr. Parzmair began a career in support for individuals with disabilities at Lebenshilfe Salzburg from 2002 to 2004. Educational qualifications include a Doctor rerum naturalium in Immunregulation from Otto-von-Guericke University Magdeburg, a Master of Science in Genetics from Paris Lodron Universität Salzburg, and a Bachelor of Science in Genetics from Universität Salzburg.
Links